Hanmi Science Expands Medical Device Business...Targeting Overseas Markets with Surgical Hemostatic Agents

Three Types of Surgical Hemostatic Agents Unveiled at 'MEDICA 2025'
Seeking Overseas Distribution Partnerships

Hanmi Science is accelerating the global expansion of its medical device business, including surgical therapeutic materials.

Hanmi Science, the holding company of Hanmi Group, announced on the 13th that it will participate in 'MEDICA 2025,' the world's largest medical device exhibition, to be held in Dusseldorf, Germany from November 17 to 20. The company plans to showcase its medical device products and technological capabilities, while strengthening its global business at the event.

Reference photo of MEDICA 2025, the world's largest medical device exhibition held in Dusseldorf, Germany. Hanmi Science

At this exhibition, three types of surgical hemostatic agents developed by Teracion Biomedical, a biosurgery specialist, and exclusively licensed for overseas sales by Hanmi Science, will be unveiled.

The featured products include: ▲Oozfix, an absorbable powder-type adjunctive hemostat; ▲Tableau Wax, a poloxamer-based absorbable bone hemostat; and ▲ActiClot, an active hemostat that combines thrombin with a starch-derived polymer matrix. These products represent the core lineup in Hanmi Science's medical device portfolio.

'Oozfix' is a powder-type absorbable hemostatic agent used for exudative bleeding sites after primary hemostasis in surgical procedures. 'Tableau Wax' is a poloxamer-based absorbable hemostat that forms a protective barrier on bone surfaces to maintain a sealing effect, and is used in surgeries such as CS, OS, and NS procedures.

'ActiClot' is an active hemostatic agent combining carboxymethyl starch and thrombin, provided in a pre-filled syringe for enhanced user convenience. Notably, it decomposes within three days in the body, minimizing side effects such as inflammation or foreign body reactions.

In particular, these products are recognized as highly competitive in the global market due to their rapid hemostatic effect and the use of starch-based materials with proven safety, excluding any animal-derived ingredients.

Hanmi Science is responsible for domestic distribution and overseas export of these products. Through this exhibition, the company aims to seek partnerships with distributors and hospital officials in key markets such as Europe, the Middle East, and Asia, and to actively promote the clinical excellence and technological strengths of its products.

An official from Hanmi Science's Medical Device Division stated, "Participating in MEDICA this year will be an important opportunity to showcase the excellence of Korean medical devices to the global market. We will further strengthen Hanmi Science's presence in the global healthcare market and continue to expand our business base overseas, starting with these three hemostatic agents."

Meanwhile, Hanmi Science is building an integrated portfolio that spans the entire healthcare lifecycle by organically connecting its surgical medical device business, health functional foods, consumer-centered consumer health platform, and its pharmaceutical-based derma cosmetic brand 'PRO-CALM' cosmetics business.